Saturday 17 October 2026
Export PRPH’s income statement to Excel — free account
ProPhase Labs, Inc.
PRPH Healthcare Diagnostics & Research
In the quarter to June 2026, revenue fell 18.9%, EPS grew 80.0%, free cash flow grew 56.7% and total debt rose 19.4%, each against the same quarter a year earlier.
0.01
0.00
0.00%
Follow PRPH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 7.98 | 17.93 | 0.00 | 0.00 | 0.00 | 0.85 | 0.00 |
Piotroski F-Score |
4 | 1 | 1 | 7 | 6 | 3 | 4 | 4 | 6 | 4 |
P/S ratio |
0.88 | 2.25 | 2.28 | 1.24 | 1.38 | 7.33 | 2.31 | 2.73 | 3.53 | 8.24 |
Altman Z-Score |
(3.59) | (3.07) | 0.99 | 6.90 | 4.03 | 3.51 | 13.75 | 6.58 | 12.90 | 0.46 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 6.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(11.41) | (7.14) | 1.40 | 8.38 | 6.21 | 1.71 | 13.95 | 8.71 | 24.87 | (4.66) |
P/Operating CF |
(3.11) | (4.32) | (106.03) | 186.97 | (23.41) | (15.73) | (53.23) | (45.96) | (20.20) | 87.12 |
Beneish M-Score |
(4.90) | — | (1.35) | (2.87) | 3.42 | (4.60) | (3.06) | (3.31) | (1.32) | (3.21) |
P/B ratio |
1.09 | 2.07 | 1.62 | 2.38 | 1.86 | 10.08 | 2.03 | 2.18 | 1.09 | 5.82 |
Price to Tangible BV |
0.00 | 0.00 | 2.51 | 3.07 | 2.59 | 12.64 | 2.98 | 2.78 | 1.23 | 14.54 |
EV/Sales |
2.19 | 4.72 | 2.55 | 1.12 | 1.29 | 7.46 | 2.47 | 2.33 | 1.61 | 8.84 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 4.78 | 7.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.14) | (1.82) | (7.51) | 4.80 | (7.49) | (41.79) | (28.99) | (14.45) | (5.60) | (78.80) |
EV/FCF |
(1.16) | (1.76) | (6.41) | 5.46 | (3.79) | (49.23) | (22.81) | (0.71) | (5.22) | (33.12) |
Quick Ratio |
0.03 | 0.65 | 1.94 | 3.39 | 3.56 | 1.84 | 8.77 | 3.79 | 14.56 | 0.91 |
Current Ratio |
0.06 | 0.95 | 2.28 | 3.78 | 3.95 | 2.52 | 10.66 | 4.31 | 15.68 | 1.41 |
Net Debt/EBITDA |
(0.74) | (0.55) | (0.46) | (0.51) | (0.51) | (1.15) | 0.48 | 6.59 | 6.02 | (0.31) |
Debt/Assets |
9.68% | 27.61% | 12.43% | 3.08% | 11.99% | 32.86% | 0.00% | 0.00% | 0.00% | 11.64% |
Debt/Equity |
1.65 | 2.37 | 0.23 | 0.04 | 0.18 | 0.98 | 0.00 | 0.00 | 0.00 | 0.25 |
Asset Turnover |
0.07 | 0.09 | 0.39 | 1.39 | 1.31 | 0.66 | 0.60 | 0.48 | 0.42 | 0.30 |
Operating CF/Net income |
0.57 | 0.33 | 0.71 | 1.55 | (2.17) | 1.22 | 0.27 | 1.22 | (0.07) | 0.16 |
Capex/Depreciation |
0.01 | (0.08) | (0.31) | (0.68) | (3.73) | 0.85 | (0.57) | (0.37) | (0.60) | (1.45) |
Interest Coverage |
(2.60) | (11.53) | (16.76) | 30.88 | 8.54 | (7.05) | (24.35) | (9.78) | (17.27) | (17.81) |
| (271.49%) | (188.11%) | (29.70%) | 30.20% | 18.13% | (19.51%) | (22.69%) | (7.20%) | 214.71% | (38.78%) | |
| (23.96%) | (68.80%) | (18.69%) | 20.87% | 10.39% | (9.73%) | (19.06%) | (6.40%) | 174.72% | (20.76%) | |
ROIC |
(122.44%) | (100.08%) | (23.65%) | 30.16% | 11.82% | (10.47%) | (20.51%) | (12.36%) | (25.17%) | (33.82%) |
Return on Tangible Assets |
30.78% | (888.81%) | (45.29%) | 35.47% | 12.12% | (16.13%) | (27.74%) | (10.54%) | 138.31% | (48.10%) |
Average Days of Receivables |
129.03 | 1,081.41 | 373.66 | 110.27 | 174.13 | 79.34 | 252.13 | 216.84 | 164.43 | 500.73 |
Research and Development Expense of Revenue |
2.46% | 8.77% | 4.01% | 0.53% | 0.66% | 4.36% | 3.36% | 3.03% | 4.37% | 8.51% |
Selling, General and Administrative Expense of Revenue |
444.74% | 559.60% | 95.59% | 28.04% | 28.46% | 51.66% | 55.91% | 45.84% | 55.81% | 105.40% |
Intangible Assets out of Total Assets |
0.19 | 0.24 | 0.19 | 0.16 | 0.19 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
43.57% | 53.74% | 10.11% | 3.25% | 4.03% | 10.05% | 7.53% | 4.83% | 0.79% | 0.02% |
Graham Net Nets |
(13.93) | (1.66) | 0.06 | 0.24 | 0.28 | (0.05) | 0.39 | 0.39 | 0.76 | 0.08 |
Graham Number |
0.00 | 0.00 | 0.00 | 104.13 | 58.97 | 0.00 | 0.00 | 0.00 | 110.31 | 0.00 |
Earnings Yield |
(386.58%) | (313.56%) | (21.12%) | 12.54% | 5.58% | (2.05%) | (14.23%) | (4.71%) | 118.00% | (8.37%) |
Free Cash Flow Yield |
(215.29%) | (119.84%) | (17.44%) | 16.54% | (24.74%) | (2.07%) | (4.69%) | (120.04%) | (8.74%) | (3.24%) |
Revenue per Share |
0.51 | 3.39 | 20.33 | 77.40 | 52.10 | 12.52 | 8.54 | 11.52 | 6.34 | 2.46 |
Operating CF per Share |
(0.98) | (8.77) | (6.91) | 18.02 | (8.98) | (2.24) | (0.73) | (1.86) | (1.82) | (0.28) |
Capex per Share |
0.01 | (0.34) | (1.18) | (2.19) | (8.76) | 0.34 | (0.20) | (0.12) | (0.13) | (0.38) |
Free Cash Flow per Share |
(0.97) | (9.11) | (8.09) | 15.83 | (17.74) | (1.90) | (0.92) | (1.98) | (1.96) | (0.66) |
Cash per Share |
0.01 | 0.34 | 2.75 | 11.00 | 11.54 | 7.29 | 1.18 | 7.23 | 14.09 | 0.26 |
Shareholders Equity per Share |
0.41 | 3.68 | 28.70 | 40.16 | 38.64 | 9.10 | 9.71 | 14.48 | 20.46 | 3.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.41 | 3.68 | 28.70 | 40.16 | 38.64 | 9.10 | 9.71 | 14.48 | 20.46 | 3.49 |
Free Cash Flow |
(8.22) | (18.21) | (13.93) | 25.08 | (26.92) | (2.20) | (1.07) | (2.26) | (3.05) | (1.12) |
Working Capital |
(49.93) | (1.50) | 26.73 | 44.76 | 45.79 | 9.59 | 9.01 | 14.01 | 26.61 | 2.79 |
Capital Expenditures |
0.12 | (0.68) | (2.04) | (3.47) | (13.30) | 0.39 | (0.23) | (0.14) | (0.21) | (0.65) |
Net Current Asset Value |
(53.21) | (25.21) | 5.04 | 36.82 | 30.65 | (4.96) | 8.90 | 14.01 | 26.61 | 2.79 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 5.80 | 10.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
(0.03) | 0.10 | 0.06 | 0.03 | 0.17 | (0.03) | 0.02 | 0.01 | 0.02 | 0.15 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 6.43 | 11.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.07 | 1.08 | 0.64 | 0.70 | 0.60 | 0.13 | 0.17 | 0.15 | 0.13 | 0.14 |
Cash ROIC |
(87.56%) | (71.48%) | (21.25%) | 29.94% | (30.99%) | (7.50%) | (8.49%) | (9.13%) | (5.66%) | (14.23%) |
Accounts Receivable Turnover |
0.40 | 0.24 | 0.96 | 3.28 | 3.87 | 2.91 | 1.35 | 2.14 | 1.93 | 0.86 |
Accounts Payable Turnover |
0.11 | 0.62 | 2.67 | 8.04 | 6.86 | 4.71 | 16.71 | 16.71 | 5.83 | 2.04 |
Inventory Turnover |
4.88 | 4.03 | 6.20 | 12.13 | 9.70 | 4.41 | 4.32 | 4.86 | 3.71 | 0.91 |
Average Days of Payables |
4,999.92 | 723.51 | 162.40 | 41.45 | 69.21 | 138.92 | 21.72 | 19.11 | 25.90 | 245.23 |
Days of Inventory on Hand |
8.63 | 60.29 | 43.04 | 27.91 | 45.31 | 111.95 | 73.34 | 83.23 | 70.57 | 311.20 |
Average Receivables |
10.80 | 27.94 | 36.43 | 37.38 | 20.43 | 4.99 | 7.31 | 6.12 | 5.11 | 4.89 |
Average Payables |
27.14 | 11.18 | 7.27 | 6.47 | 5.40 | 2.10 | 0.43 | 0.50 | 1.36 | 1.57 |
Average Inventory |
0.61 | 1.72 | 3.13 | 4.29 | 3.82 | 2.25 | 1.68 | 1.72 | 2.13 | 3.53 |
Average Assets |
61.54 | 77.56 | 89.79 | 88.47 | 60.35 | 21.84 | 16.51 | 27.20 | 23.23 | 13.82 |
Average Common Equity |
5.43 | 28.37 | 56.51 | 61.13 | 34.59 | 10.89 | 13.87 | 24.18 | 18.90 | 7.40 |
Columns are period end dates